PNC Financial Services Group’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-113
Closed 4426
2017
Q4
$0 Buy
+113
New +$615 ﹤0.01% 4406
2016
Q3
Sell
-76
Closed -$1K 4675
2016
Q2
$1K Sell
76
-3
-4% -$37 ﹤0.01% 4478
2016
Q1
$1K Buy
79
+3
+4% +$35 ﹤0.01% 4478
2015
Q4
$2K Hold
76
﹤0.01% 4284
2015
Q3
$1K Buy
76
+3
+4% +$56 ﹤0.01% 4589
2015
Q2
$2K Buy
73
+25
+52% +$591 ﹤0.01% 4517
2015
Q1
$1K Hold
48
﹤0.01% 4648
2014
Q4
$1K Buy
+48
New +$1.33K ﹤0.01% 4126

Other funds holding IMDZ

PNC Financial Services Group's IMDZ Position: Q1 2018 in Review

PNC Financial Services Group sold out of Immune Design Corp. (IMDZ) in Q1 2018, closing a stake of 113 shares.

PNC Financial Services Group first reported a position in IMDZ in Q4 2014 and held it in 8 quarters. The position peaked at $2K in Q4 2015. 72 funds tracked by Wall St. Rank hold IMDZ as of Q1 2018.

  • PNC Financial Services Group reported no remaining Immune Design Corp. position as of Q1 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 113 Immune Design Corp. shares in Q1 2018.
  • PNC Financial Services Group first reported a position in Immune Design Corp. in Q4 2014 and held it in 8 quarters.
  • PNC Financial Services Group's Immune Design Corp. position peaked at $2K in Q4 2015.
  • 72 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2018.

Based on PNC Financial Services Group's 13F filing for Q1 2018, filed 11 May 2018.